Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Immunogenetics|June 5, 2015
Association analysis of -416 G>C polymorphism of T-cell immunoglobulin and mucin domain-1 gene with asthma in IranH Shirzade, R Meshkat, M Ganjalikhani-Hakemi, et al.Neuro-Oncology|January 31, 2026
A brief history of ependymomaDavid R Ghasemi, Denise Obrecht-Sturm, Kimberly M Wallgren, et al.Journal of Clinical Medicine|July 29, 2025
Assessing LLMs on IDSA Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis: A Comparison StudyFilip Milicevic, Maher Ghandour, Moh'd Yazan Khasawneh, et al.Oncogenesis|September 2, 2014
Membranous Nectin-4 expression is a risk factor for distant relapse of T1-T2, N0 luminal-A early breast cancerR Lattanzio, R Ghasemi, F Brancati, et al.Genome Biology|June 20, 2025
Comparison of spatial transcriptomics technologies using tumor cryosectionsAnne Rademacher, Alik Huseynov, Michele Bortolomeazzi, et al.Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Extrachromosomal DNA associates with poor survival across a broad spectrum of childhood solid tumorsOwen S Chapman, Sunita Sridhar, Eugene Yui-Ching Chow, et al.Neuro-Oncology|March 14, 2023
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA studyRebecca J Chapman, David R Ghasemi, Felipe Andreiuolo, et al.Nature Communications|November 23, 2024
Multi-omic and single-cell profiling of chromothriptic medulloblastoma reveals genomic and transcriptomic consequences of genome instabilityPetr Smirnov, Moritz J Przybilla, Milena Simovic-Lorenz, et al.Acta Neuropathologica|November 30, 2019
Transcriptional profiling of medulloblastoma with extensive nodularity (MBEN) reveals two clinically relevant tumor subsets with VSNL1 as potent prognostic markerAndrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.Pageof 5